Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data

The ChAdOx1 nCoV-19 (ChA) (AstraZeneca) and Ad26.COV2.S (AD26) (Janssen) vaccines are virus-based coronavirus disease 2019 (COVID-19) vaccines used worldwide. In spring 2021, venous blood clots and thrombocytopenia were described in some vaccine recipients. We evaluated the frequency of severe adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Cari, Luigi, Alhosseini, Mahdieh Naghavi, Fiore, Paolo, Pierno, Sabata, Pacor, Sabrina, Bergamo, Alberta, Sava, Gianni, Nocentini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547775/
https://www.ncbi.nlm.nih.gov/pubmed/34710832
http://dx.doi.org/10.1016/j.jaut.2021.102742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547775/
https://www.ncbi.nlm.nih.gov/pubmed/34710832
http://dx.doi.org/10.1016/j.jaut.2021.102742

Ejemplares similares